logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Myeloid Leukemia Methods And Protocols 1st Edition Harry Iland

  • SKU: BELL-1312850
Myeloid Leukemia Methods And Protocols 1st Edition Harry Iland
$ 31.00 $ 45.00 (-31%)

4.4

32 reviews

Myeloid Leukemia Methods And Protocols 1st Edition Harry Iland instant download after payment.

Publisher: Humana Press
File Extension: PDF
File size: 9.03 MB
Pages: 319
Author: Harry Iland, Mark Hertzberg, Paula Marlton
ISBN: 9781588294852, 9781597450171, 1588294854, 1597450170
Language: English
Year: 2005
Edition: 1

Product desciption

Myeloid Leukemia Methods And Protocols 1st Edition Harry Iland by Harry Iland, Mark Hertzberg, Paula Marlton 9781588294852, 9781597450171, 1588294854, 1597450170 instant download after payment.

A panel of internationally recognized research scientists and clinical investigators brings together a diverse collection of readily reproducible methods for identifying and quantifying a large number of specific genetic abnormalities associated with the broad spectrum of myeloid malignancies. Highlights include techniques for the detection of BCR-ABL mutations and resistance to imatinib mesylate, detection of the FIP1L1-PDGFRA fusion in idiopathic hypereosinophilic syndrome and chronic eosinophilic leukemia, classification of AML by DNA-oligonucleotide microarrays, and detection of the V617F JAK2 mutation in myeloproliferative disorders. In addition to gene rearrangments, other prognostically relevant molecular lesions such as FLT3 mutations and WT-1 overexpression are covered.

Related Products